We understand that breast cancer drugs are vitally important to many people in this country. Our \u2018no deal\u2019 European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.<\/p>
<\/p>
In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a \u2018no deal\u2019 scenario. The duration of the stockpiling requirement was based on the Government\u2019s reasonable worst-case scenario border disruption planning assumptions.<\/p>
<\/p>
We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.<\/p>
<\/p>
The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department\u2019s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "221000"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:19:26.903Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many weeks\u2019 worth of medicines the Government has asked pharmaceutical companies to stockpile as part of preparations for the UK leaving the EU without a deal; and how his Department decided on that period of duration.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4610", "label" : {"_value" : "Biography information for Bambos Charalambous"} } , "tablingMemberConstituency" : {"_value" : "Enfield, Southgate"} , "tablingMemberPrinted" : [{"_value" : "Bambos Charalambous"} ], "uin" : "220998"} , {"_about" : "http://data.parliament.uk/resources/1060594", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060594/answer", "answerText" : {"_value" : "
We understand that breast cancer drugs are vitally important to many people in this country. Our \u2018no deal\u2019 European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.<\/p>
<\/p>
In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a \u2018no deal\u2019 scenario. The duration of the stockpiling requirement was based on the Government\u2019s reasonable worst-case scenario border disruption planning assumptions.<\/p>
<\/p>
We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.<\/p>
<\/p>
The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department\u2019s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "220998"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:19:26.943Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Breast Cancer: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what information he holds on those NHS breast cancer drugs that pharmaceutical companies will have six weeks' supply of by 29 March 2019.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4610", "label" : {"_value" : "Biography information for Bambos Charalambous"} } , "tablingMemberConstituency" : {"_value" : "Enfield, Southgate"} , "tablingMemberPrinted" : [{"_value" : "Bambos Charalambous"} ], "uin" : "221000"} , {"_about" : "http://data.parliament.uk/resources/1060618", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060618/answer", "answerText" : {"_value" : "
Of the £71.1 million funding the Department has been allocated for 2018/19 and 2019/20 for preparations for European Union exit, we are unable to provide a breakdown of the amount of funding allocated to \u2018no deal\u2019 preparations specifically, as this cannot be separated from EU exit work as a whole across the Department.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:21:35.637Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Department of Health and Social Care: Brexit"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the cost to the public purse of his Department's preparations for the UK leaving the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"} } , "tablingMemberConstituency" : {"_value" : "Coventry South"} , "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"} ], "uin" : "220768"} , {"_about" : "http://data.parliament.uk/resources/1060620", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060620/answer", "answerText" : {"_value" : "
If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.<\/p>
<\/p>
The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.<\/p>
<\/p>
People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a \u2018no-deal\u2019 scenario and so that they are aware of and can agree to any potential charges before booking travel.<\/p>
<\/p>
Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "220903"} , {"_value" : "220904"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:22:51.677Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: British Nationals Abroad"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, what advice he has for people on kidney dialysis who wish to travel in the EU or EEA and to whom his advice of 28 January 2019 does not cover because dialysis is not covered under travel insurance.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4127", "label" : {"_value" : "Biography information for Julie Elliott"} } , "tablingMemberConstituency" : {"_value" : "Sunderland Central"} , "tablingMemberPrinted" : [{"_value" : "Julie Elliott"} ], "uin" : "220902"} , {"_about" : "http://data.parliament.uk/resources/1060621", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060621/answer", "answerText" : {"_value" : "
If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.<\/p>
<\/p>
The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.<\/p>
<\/p>
People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a \u2018no-deal\u2019 scenario and so that they are aware of and can agree to any potential charges before booking travel.<\/p>
<\/p>
Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "220902"} , {"_value" : "220904"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:22:51.727Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: British Nationals Abroad"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, when he will issue an update to that advice for people on kidney dialysis who wish to travel to the EU or EEA.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4127", "label" : {"_value" : "Biography information for Julie Elliott"} } , "tablingMemberConstituency" : {"_value" : "Sunderland Central"} , "tablingMemberPrinted" : [{"_value" : "Julie Elliott"} ], "uin" : "220903"} , {"_about" : "http://data.parliament.uk/resources/1060622", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060622/answer", "answerText" : {"_value" : "
If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.<\/p>
<\/p>
The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.<\/p>
<\/p>
People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a \u2018no-deal\u2019 scenario and so that they are aware of and can agree to any potential charges before booking travel.<\/p>
<\/p>
Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "220902"} , {"_value" : "220903"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:22:51.773Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: British Nationals Abroad"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what advice he has on compensation to people on dialysis who book, or who have already booked, travel to the EU or EEA and who have to cancel it because they are unable to secure State-funded dialysis treatment whilst they are away.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4127", "label" : {"_value" : "Biography information for Julie Elliott"} } , "tablingMemberConstituency" : {"_value" : "Sunderland Central"} , "tablingMemberPrinted" : [{"_value" : "Julie Elliott"} ], "uin" : "220904"} , {"_about" : "http://data.parliament.uk/resources/1060643", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060643/answer", "answerText" : {"_value" : "
Our number one priority is to ensure patients continue to have unhindered access to medicines as we exit the European Union and we are working with all sectors in the supply chain to ensure this happens.<\/p>
<\/p>
The Government remains committed to leaving the EU with a deal. Under the conditions of the Withdrawal Agreement, there will be a two-year Implementation Period within which the Government will negotiate the United Kingdom\u2019s future relationship with the EU. During the Implementation Period, there will be no change to the current trading arrangements with the EU/European Economic Area (EEA), meaning the supply of medicines and medical products will continue unhindered.<\/p>
<\/p>
As a responsible Government, we are planning for all possible exit scenarios, including \u2018no deal\u2019. Our \u2018no deal\u2019 medicines supply contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/ EEA to ensure that the supply of essential medicines, is not disrupted.<\/p>
<\/p>
In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. The response from industry has been very positive. The vast majority of companies have confirmed stockpiling plans are in place.<\/p>
<\/p>
On 7 December, the Government published updated reasonable worst-case scenario border disruption planning assumptions in the event of a \u2018no deal\u2019 EU exit. Medicines and medical products are prioritised in cross-Government planning, and the Department is working with relevant partners across Government and industry to ensure we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely into the UK.<\/p>
<\/p>
We are confident that if everyone does what they need to do, supplies will continue unhindered. The Department does not expect to see significant changes to existing medicine supply chains or capacity in the intervening period between now and 29 March 2019, although we will be monitoring this closely.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:10:21.83Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the UK leaving the EU on 29 March 2019 on the supply of medicines to the UK for NHS use.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1400", "label" : {"_value" : "Biography information for Kevin Brennan"} } , "tablingMemberConstituency" : {"_value" : "Cardiff West"} , "tablingMemberPrinted" : [{"_value" : "Kevin Brennan"} ], "uin" : "220816"} , {"_about" : "http://data.parliament.uk/resources/1060724", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060724/answer", "answerText" : {"_value" : "
The United Kingdom Government appreciates the importance of retaining reciprocal healthcare arrangements with the European Union, and has been clear in the negotiations that it wants to protect the rights of UK citizens in the EU.<\/p>
Subject to the Withdrawal Agreement being agreed by Parliament, during the implementation period the current rules on reciprocal healthcare will continue until December 2020. The rights of UK nationals living in the EU, and who fall within the scope of the Withdrawal Agreement, will continue to be protected after December 2020, for as long as these individuals remain in scope of the Withdrawal Agreement. This includes state pensioners already benefiting from that cover.<\/p>
The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover in a \u2018no deal\u2019 scenario.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:18:09.507Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: British Nationals Abroad"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what arrangements will be in place to provide healthcare cover for UK state pensioners who reside in the EU after the UK leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4505", "label" : {"_value" : "Biography information for Peter Kyle"} } , "tablingMemberConstituency" : {"_value" : "Hove"} , "tablingMemberPrinted" : [{"_value" : "Peter Kyle"} ], "uin" : "220982"} , {"_about" : "http://data.parliament.uk/resources/1060783", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060783/answer", "answerText" : {"_value" : "
The Government has introduced legislation that will largely maintain existing arrangements for the recognition of European health and care qualifications. European qualifications that are currently recognised automatically by United Kingdom regulators (doctors, nurses, midwives, dentists and pharmacists), will continue to be recognised after the UK leaves the European Union. European qualifications that are not accepted automatically will continue to be assessed against the standard of UK qualifications, as is currently the case.<\/p>
<\/p>
UK regulators have been preparing for a possible 'no-deal' scenario. As the legislation introduced maintains the current systems as far as is possible for at least two years upon coming into force, little impact is expected after exit day. No additional funding has been allocated.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-18T15:20:41.987Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Professions: Regulation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what additional resources have been allocated to regulators of the health professions to support them with the potential increased workload of maintaining their registers in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4058", "label" : {"_value" : "Biography information for Paul Blomfield"} } , "tablingMemberConstituency" : {"_value" : "Sheffield Central"} , "tablingMemberPrinted" : [{"_value" : "Paul Blomfield"} ], "uin" : "220892"} , {"_about" : "http://data.parliament.uk/resources/1060807", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1060807/answer", "answerText" : {"_value" : "
Data on nursing applications is not held at local authority and parliamentary constituency level. Data on applications is not available for 2019 entry.<\/p>
<\/p>
The following table shows the number of applications made to nursing and midwifery courses in each United Kingdom nation.<\/p>
<\/p>
Number of applications to nursing and midwifery courses, split by UK country of provider and entry year<\/p>
Entry year<\/p><\/td> | 2015<\/p><\/td> | 2016<\/p><\/td> | 2017<\/p><\/td> | 2018<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||
English providers<\/p><\/td> | 194,075<\/p><\/td> | 196,260<\/p><\/td> | 150,970<\/p><\/td> | 126,000<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||
Northern Irish providers<\/p><\/td> | 7,220<\/p><\/td> | 7,330<\/p><\/td> | 6,750<\/p><\/td> | 6,325<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||
Scottish providers<\/p><\/td> | 21,105<\/p><\/td> | 20,725<\/p><\/td> | 20,900<\/p><\/td> | 20,435<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||
Welsh providers<\/p><\/td> | 9,885<\/p><\/td> | 10,445<\/p><\/td> | 9,490<\/p><\/td> | 9,810<\/p><\/td><\/tr><\/tbody><\/table> Source: Universities and Colleges Admissions Service (UCAS) published end of cycle data<\/p> <\/p> The following table shows the number of applications made to nursing and midwifery courses in each region of England.<\/p> <\/p> Number of applications to nursing and midwifery courses, split by English region of provider and entry year<\/p>
|